Tukysa 150 MG tablet UU 120S
Ended Awarded
- Contract number
- SPE2DB25FRCFG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,756
Award facts
- Contract value 100% obligated
- $15,756.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of TUKYSA 150 mg tablets (120-count units) valued at $15,756.32 under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by June 26, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs through its extensive portfolio of delivery orders with the Defense Logistics Agency. The company's DLA contracts demonstrate consistent capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, from specialty medications to vaccines and medical supplies, supporting military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company maintains active engagement with the DLA's evolving Pharmaceutical Prime Vendor Global Program, reflecting its strategic importance to the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FRCFG?
SPE2DB25FRCFG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 4, 2025.
How much is contract SPE2DB25FRCFG worth?
The government has obligated $15,756 on SPE2DB25FRCFG.
Is contract SPE2DB25FRCFG an order under another contract?
Yes. SPE2DB25FRCFG is a delivery order under SPE2DB25D3008, an indefinite delivery contract.
Was contract SPE2DB25FRCFG competed?
The extent of competition for SPE2DB25FRCFG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award